Biobizkaia
Forschungszentrum
Cleveland Clinic
Cleveland, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Cleveland Clinic (27)
2024
-
The “Woundosome” Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia
Journal of Endovascular Therapy
2023
-
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804
-
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
Psychiatry Research, Vol. 319
-
Heart rate and QRS duration as biomarkers predict the immediate outcome from pulseless electrical activity
Resuscitation, Vol. 185
2022
-
Pulseless electrical activity in in-hospital cardiac arrest – A crossroad for decisions
Resuscitation, Vol. 176, pp. 117-124
2021
-
Early Allograft Dysfunction and Complications in DCD Liver Transplantation: Expert Consensus Statements from the International Liver Transplantation Society
Transplantation, Vol. 105, Núm. 8, pp. 1643-1652
2020
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151
-
Standardization of Nomenclature for Ocular Tuberculosis–Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop
Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 74-84
-
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings
Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 85-95
2018
-
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Biochemical Pharmacology, Vol. 157, pp. 189-201
-
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis
Neuropharmacology, Vol. 141, pp. 181-191
2017
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
2016
2015
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2014
-
A unified nomenclature and amino acid numbering for human PTEN
Science Signaling, Vol. 7, Núm. 332